Letters and Corrections1 November 1986Erectile Function and NaltrexoneJAY A. GOLDSTEIN, M.D.JAY A. GOLDSTEIN, M.D.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-105-5-799_1 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptTo the editor: The male patient with erectile dysfunction who has had normal findings on urologic, endocrinologic, and hemodynamic evaluations is usually referred for sexual counseling with his partner or, possibly, for individual psychotherapy. When these approaches are not helpful, he may be classed as having "idiopathic" dysfunction and be left with the choices of papaverine injection, penile prosthesis insertion, or no further medical treatment. Treatment with naltrexone might provide another alternative.Seven middle-aged men had not been able to achieve a firm erection or ejaculation for a minimum of 2 years. After extensive workup, they were classed as having...Reference1. BERENDSENGOWER HA. Opiate-androgen interactions in drug-induced yawning and penile erections in the rat. Neuroendocrinology. 1986;42:185-90. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: JAY A. GOLDSTEIN, M.D.Affiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byA Phase 2a Multicenter, Double‐Blind, Placebo‐Controlled, Crossover Trial to Investigate the Efficacy, Safety, and Toleration of CP‐866,087 (a High‐Affinity Mu‐Opioid Receptor Antagonist) in Premenopausal Women Diagnosed with Female Sexual Arousal Disorder (FSAD)Sexual inactivity results in reversible reduction of LH bioavailabilityPharmacological Aspects of Erectile DysfunctionMale Sexual Function and Its Disorders: Physiology, Pathophysiology, Clinical Investigation, and TreatmentNaltrexone-Induced Augmentation of Sexual Response in MenOral, Transdermal, and Transurethral Therapies for Erectile DysfunctionOral treatments for erectile dysfunctionNeurotransmetteurs cérébraux et contrôle du comportement sexuel masculinPharmacology of erection: Agents which initiate and terminate erectionPractical management of erectile dysfunctionNew Treatments for Erectile ImpotencePharmacological Enhancement of Human Sexual BehaviorFacteurs psychologiques et conjugaux de l'impuissance: Toujours d'actualiteNeuroendocrine control of male reproductive function. The opioid system as a model of control at multiple sitesEndorphins in male impotence: Evidence for naltrexone stimulation of erectile activity in patient therapyAssessment of erectogenic properties of apomorphine and yohimbine in man. 1 November 1986Volume 105, Issue 5Page: 799-799KeywordsEjaculationErectile dysfunctionHemodynamics ePublished: 1 December 2008 Issue Published: 1 November 1986 PDF downloadLoading ...
No takes yet. Share an insight, caveat, or question.
Jay A. Goldstein (1986) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: